FindTrial
Sign In

Major adverse of head and neck cancer patients with Particle Therapy:a retrospective study

Major adverse of head and neck cancer patients with Particle Therapy:a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084625
Enrollment
Unknown
Registered
2024-05-21
Start date
2023-01-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer

Interventions

case group:None
control group:None

Sponsors

Shanghai Proton and Heavy Ion Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ?18-80 years-old; ?Patients who diagnosed with head and neck cancer and receiving particle radiotherapy; ?Patients with intact oral cavity and skin before radiotherapy ?Completed all treatment successfully.

Exclusion criteria

Exclusion criteria: ?Associated with other tumors; ?Receive palliative radiotherapy.

Design outcomes

Primary

MeasureTime frame
Moderate to severe Radiation-induced Oral Mucositis;—

Secondary

MeasureTime frame
Moderate to severe Radiation-induced Dermatitis;Moderate to severe Radiation-induced Xerostomia;—

Countries

China

Contacts

Public ContactYu Zhu

Shanghai Proton and Heavy Ion Center

yuzhu@sphic.org.cn+86 188 1736 5870

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026